Penumbra Inc (PEN)
Penumbra Inc (PEN) from its SEC filings: 2025 revenue $1.4 billion (+18% vs the year before), net margin 13%, free cash flow $174.9 million. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Surgical & Medical Instruments & Apparatus |
| Revenue (2025) | $1.4 billion |
| Revenue growth | +18% |
| Net income | $177.7 million |
| Net margin | 12.7% |
| Free cash flow | $174.9 million |
| Diluted EPS | $4.52 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +15% |
| Cash | $205.3 million |
| Share count, 1 year | +1% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-20. Education only, not financial advice.